jeff smith starboard kenvue news

Kenvue, Starboard Value

Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says (update)

Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder and CEO of activist hedge fund Starboard Value said. "We are having conversations with them and there are signs that Kenvue is already going in the right direction,

Reuters · 1d

Starboard says Kenvue's skin health segment weighing on performance

Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster growth is the reason for the stock's underperformance.

Barron's on MSN · 2d

Starboard Targets Another Health Company. Why Kenvue Is in Its Sights.

Tylenol, Listerine and Band-Aid maker Kenvue is the latest in the health related sector to attract an activist investor. And not just any corporate agitator, Starboard Value, which in recent days targeted pharma giant Pfizer.

Pfizer, Starboard Value

CNBC on MSN · 1d

Starboard Value CEO Jeff Smith: Pfizer needs to do a better job disciplining itself on investments

Jeff Smith, Starboard Value CEO, joins CNBC's 'Squawk on the Street' to discuss how he sees Pfizer going forward, potential for growth in Kenvue, and more.

Wall Street Journal · 1d

Starboard Chief Criticizes Pfizer’s R&D Investments

Activist hedge fund Starboard Value believes the root cause of Pfizer’s issues are the low expected returns on its research and development investments, including investments done both internally and through mergers and acquisitions.

Reuters on MSN · 1d

Starboard Value CEO says Pfizer's board should hold management accountable

Activist hedge fund Starboard Value's chief investment officer Jeffrey Smith said on Tuesday that drugmaker Pfizer Inc's board needs to hold management accountable for its underperformance. "We measure success in producing blockbuster drugs and we all get measured by our track records.

14h

Starboard Focused on Kenvue's Struggling Unit

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

BioSpace1d

Activist Investor Starboard Takes Aim at J&J Spinoff Kenvue on Heels of $1B Stake in Pfizer

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...

FiercePharma2d

Activist investor Starboard sets its sights on J&J spinout Kenvue: WSJ

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...

2don MSN

Tylenol Maker Kenvue Stock Surges on Report Starboard Takes 'Sizable Stake'

Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

2don MSN

Activist Starboard could push for Kenvue to sell some/all of its SHB business - analyst

Financial writer highlights activist investor Starboard Value's push for Kenvue (KVUE) to divest its challenged skin, ...

2don MSN

What's Going On With Kenvue Stock Monday?

Kenvue Inc. (NYSE:KVUE) shares are moving higher Monday following a report suggesting activist investor Starboard Value has ...

Starboard has sizable stake in Kenvue, wants changes, WSJ reports

Starboard Value has a sizable stake in Kenvue (KVUE) and wants the company to make changes to boost its share price, Lauren Thomas of Wall ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results